Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.

Chen, Wei-Chung; Wu, Chun-Chieh; Chen, Yi-Hsun; Lee, Jui-Ying; Wang, Yao-Kuang; Wu, Nian-Siou; Wu, Ming-Tsang; Wu, I-Chen

Chen, Wei-Chung; Wu, Chun-Chieh; Chen, Yi-Hsun; Lee, Jui-Ying; Wang, Yao-Kuang; Wu, Nian-Siou; Wu, Ming-Tsang; Wu, I-Chen.

Afiliação

Chen WC; Ph.D. Program in Environmental and Occupational Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Wu CC; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Chen YH; Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Lee JY; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Wang YK; Division of Thoracic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Wu NS; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Wu MT; Faculty of Medicine, Department of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Wu IC; School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

Biomedicines ; 10(8)2022 Aug 04.

Article em En | MEDLINE | ID: mdl-36009434

Palavras-chave

CD8; PD-L1; concurrent chemoradiation therapy; esophageal squamous cell carcinoma; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google